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Adipose tissue (AT) forms depots at different anatomical locations throughout the body,
being in subcutaneous and visceral regions, as well as the bone marrow. These ATs
differ in the adipocyte functional profile, their insulin sensitivity, adipokines’ production,
lipolysis, and response to pathologic conditions. Despite the recent advances in lineage
tracing, which have demonstrated that individual adipose depots are composed of
adipocytes derived from distinct progenitor populations, the cellular and molecular
dissection of the adipose clonogenic stem cell niche is still a great challenge. Additional
complexity in AT regulation is associated with tumor-induced changes that affect
adipocyte phenotype. As an integrative unit of cell differentiation, AT microenvironment
regulates various phenotype outcomes of differentiating adipogenic lineages, which
consequently may contribute to the neoplastic phenotype manifestations. Particularly
interesting is the capacity of AT to impose and support the aberrant potency of stem
cells that accompanies tumor development. In this review, we summarize the current
findings on the communication between adipocytes and their progenitors with tumor
cells, pointing out to the co-existence of healthy and neoplastic stem cell niches
developed during tumor evolution. We also discuss tumor-induced adaptations in
mature adipocytes and the involvement of alternative differentiation programs.
Keywords: adipose tissue depots, adipogenesis, trans-differentiation, tumor, microenvironment, adipose tissue
remodeling, stem cell niche
INTRODUCTION
Adipose tissue (AT) is a loose connective tissue responsible for lipid storage, which also serves as an
important protector from excess levels of lipids and glucose (Abate, 2012). Scattered throughout
the body, without uniform organization and anatomy, different AT compartments participate
in systemic and regional control of the overall energy metabolism and signaling, while their
secretomes act locally (paracrine function) and systemically (endocrine function).
The functional classification of AT recognizes energy-storing white adipocytes as the
predominant cell type of white adipose tissue (WAT) and heat-dissipating brown adipocytes in
brown adipose tissue (BAT) with distinct cellular organizations and metabolic and endocrine
functions. However, the delineation of adipocyte phenotypes is not strict, since brown adipocytes
were found sporadically in the WAT of mice (Lucchini et al., 2020). Also, an intermediate adipocyte
profile characterizes beige or “brite” adipocytes, which represent an inducible form of thermogenic
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adipocytes sporadically residing within WAT (Bukowska et al.,
2018; Schoettl et al., 2018). Although both WAT and BAT
adipocytes can store large amounts of lipids, their main
functional differences relate to the higher oxidative capacity and
energy expenditure by BAT under nervous/endocrine control
(Alemany, 2011). While BAT depots are primarily found in
rodent and human infants, their increased activity in adults
can be demonstrated upon cold exposure, noradrenergic and
pharmacological stimulation, or fasting.
Depending on their anatomical location, adipose depots are
broadly classified into the subcutaneous, intramuscular, visceral,
and bone marrow subtypes (Vaitkus and Celi, 2017). In humans,
subcutaneous adipose tissue depots (SAT) serve as entity of
energy storage and protection against mechanical damage and
heat loss (Alexander et al., 2015; Kasza et al., 2019). Visceral
adipose tissue (VAT) stores abdominal triglycerides forming a
coating layer over the vital organs in the omentum and the
retroperitoneal space. Bone marrow adipose tissue (BMAT), also
referred to as yellow AT, is another, distinct AT subtype inhabiting
the rigid bone cavity, which regulates hematopoiesis, the skeletal
system, paracrine/endocrine signaling, and energy metabolism
(Suchacki and Cawthorn, 2018).
Both classifications of AT reflect its heterogeneity at a cellular
level and anatomical localizations, thus compromising the
understanding functional differences between adipocytes
and their associations with the development of various
diseases. This review summarizes the data on the AT
microenvironment at different body depots and its remodeling
during tumor development.
Adipose Tissue Niche Constituents
In addition to adipocytes, the complex biological entity of
the AT niche includes endothelial cells, macrophages, and
other immune cells and a small size population of stem cells
within adipose stromal cells (ASCs) (Kim et al., 2014). AT
homeostasis and remodeling are regulated by the interactions of
these cells residing within a specific milieu of secreted factors
and an extracellular matrix (ECM). Depending on the depot
location, health status, age, and gender, variations were found
in cellular composition, the ASC compartments, vascularity,
the content of the ECM, metabolism, and the secretome of
the AT niche (Lee et al., 2013). While large, insulin-resistant
adipocytes, which are more sensitive to lipolysis, characterize
VAT with a rich vasculature and innervation, containing higher
levels of macrophages, T cells, and natural killer cells, SAT
is characterized by small insulin-sensitive adipocytes, lower
vascularity, innervation, and immune cell infiltration (Ibrahim,
2010). Compared with the other AT depots, BMAT displays
distinctive features as a more heterogeneous depot containing
adipocytes of divergent phenotypes (Hardouin et al., 2016) that
display a specific cholesterol-orientated lipid metabolism devoid
of lipolytic activity (Attané et al., 2020).
The functional differences of AT depots result from
the heterogeneity of ASCs influenced by specific depot
microenvironments. The lobules as structural units within
human AT depots are composed of two ECM compartments,
stroma and septa. This was proposed to delineate the niches
of progenitor subsets: the stromal vascular fraction (SVF)
containing AT progenitors (APs) (CD45−CD34+CD31−ALPL+)
and the fibrous septa mostly inhabited by myofibroblast
progenitors (CD45−CD34+CD31−CD271high), which are
distributed differently in SAT and VAT (Estève et al., 2019). De
novo adipogenesis takes place in proximity to the vasculature,
particularly in the tunica media and tunica adventitia, where
pericytes and fibroblasts share a similar mesenchymal phenotype
with overlapping expressions of PDGFRα (fibroblasts) and
PDGFRβ (pericytes) (Jiang et al., 2014; Guimarães-Camboa
and Evans, 2017; Sun et al., 2019). Lineage-tracing studies
revealed that during development, BAT uncoupling protein
1 (UCP1)-expressing adipocytes derived from Myf5+ and
Pax7+ cells, while WAT adipocyte developed from PDGFRα-
and PDGFRβ-expressing cells (Ikeda et al., 2018). Although
cultured stromal vascular fraction (SVF) pericytes displayed
multilineage differentiation capacity in vitro and in vivo (Lin
et al., 2008; Rodeheffer et al., 2008), lineage-tracing experiments
investigating WAT and BAT of mice showed that pericytes
did not behave as APs in vivo (Guimarães-Camboa et al.,
2017), while fibroblast progenitors undergoing adipogenesis
acquired a beige phenotype before their differentiation into
mature WAT cells (Cattaneo et al., 2020). In addition to the
lower number of APs found in VAT (Tchkonia et al., 2005),
a study utilizing the transplantation approach demonstrated
that the proliferation and the differentiation of mouse APs
(Lin−CD29+CD34+) are influenced by the depot and their
context-specific microenvironment, suggesting that APs
represent functionally plastic cells (Jeffery et al., 2016). Human
abdominal SAT-derived APs were shown to have an increased
adipogenesis and growth rate than VAT-derived APs, with a
reduced susceptibility to lipolysis, suggesting that adult APs
display differences inherent to the AT source (Tchkonia et al.,
2006; Gealekman et al., 2011; Baglioni et al., 2012). Single-cell (sc)
RNA profiling of mouse VAT-derived SVF identified adipogenic
subpopulation Ly6C−CD9−PDGFRβ+ as adipocyte precursors
and Ly6C+ PDGFRβ+ as fibro-inflammatory progenitors, where
labeling and tracing of PDGFRβ-expressing cells in VAT allowed
deconvolution of these functionally distinct APs (Hepler et al.,
2018). Furthermore, analysis of mouse Lin−CD29+CD34+Sca-
1+ and corresponding population in human AT revealed that
a high expression of additional markers, CD142 and ABCG1
(cholesterol transporter), are associated with the presence
of APs with decreased adipogenic potential, the so-called
regulatory adipocytes (Schwalie et al., 2018). Thus, hierarchical
organization of ASCs implies the existence of specialized
progenitor entities involved in regulation of adipogenesis
and inflammation, bringing an additional complexity to the
adipogenic progenitor niche.
On the one hand, marrow adipocyte develops from bone
marrow mesenchymal stromal cells (BM-MSCs), where their
precursors share the features of osteoblasts, expressing leptin
receptors (Zhou et al., 2014), osterix (Mizoguchi et al., 2014),
and nestin, as described in animal models (Horowitz et al.,
2017). On the other hand, human BM-MSCs in vitro did not
recapitulate marrow adipogenesis or the functional properties
of BMAT, such as reduced lipolysis (compared with SAT)
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and a cholesterol-based metabolism (Scheller et al., 2016;
Attané et al., 2020). The phenotype of the BMAT progenitors is
still unknown, while a recent study based on large-scale scRNA-
sequencing data indicated the existence of nonproliferative
marrow APs in mice, which are responsible for BMAT formation
(Zhong et al., 2020).
Nevertheless, the heterogeneity of different AP phenotypes,
their overlapping features, and their relations to cellular
functionality remain to be elucidated. Certainly, detailed insights
into the architecture of AT depots, their cellular composition,
and secretome will improve the understanding of each AT depot
microenvironment in its specificity.
The Course of Adipogenesis and the
Dynamic (Inter) Conversion of the
Adipocyte Phenotype
Although the pool of adipocytes is set during childhood and
remains constant through adulthood, it may be increased
upon early-onset overnutrition, through obesity, or even
caloric restriction in the case of BMAT (Abate, 2012;
Cawthorn et al., 2016). The increase in AT mass can occur
through adipocyte hypertrophy (lipid-accumulation-induced
enlargement) and hyperplasia (the proliferation/differentiation
of stem cells/preadipocytes resulting in increased adipocyte
numbers), and these processes are followed by chronic tissue
inflammation and fibrosis (Hepler et al., 2018; Kahn et al.,
2019). Learning from in vitro and in vivo rodent models,
adipogenic differentiation involves a set of gradual stages
including stem cells/preadipocyte growth arrest, mitotic clonal
expansion, terminal differentiation, and maturation (Tang and
Lane, 2012; Chen et al., 2017). Even though the mechanisms
underlying adipogenic differentiation are not fully elucidated,
the importance of the transcriptional regulator Zfp423 (Gupta
et al., 2012) and balance of PDGFRα/PDGFRβ signaling in the
regulation of progenitor commitment to beige (PDGFRα) or
white (PDGFRβ) adipocytes has been demonstrated (Gao et al.,
2018). Moreover, during adipogenesis, sequential transcriptional
regulation in preadipocytes by peroxisome proliferator-activated
receptor-γ (PPARγ), CCAAT-enhancer-binding proteins, and
PPARγ coactivator 1-α, guides the mitochondrial biogenesis
and increased oxygen consumption rate of the differentiated
adipocytes (Lee et al., 2019).
Mitochondria are key organelles controlling adipocyte
differentiation, lipid homeostasis, insulin responsiveness,
oxidative capacity, and adaptive thermogenesis in adipocytes
(Sanchez-Gurmaches et al., 2016; Lee et al., 2019). All these
processes appeared to be involved in dynamic phenotype
conversion, which is characteristic of WAT browning and BAT
whitening. WAT adipocytes have fewer, elongated mitochondria
selectively expressing proteins that support lipogenesis and
degrade xenobiotics. Compared with WAT, BAT adipocytes
possess larger mitochondria featured by a higher expression
level of UCP1, fatty acid oxidation-related enzymes such as
acetyl-CoA dehydrogenase and catabolic metabolism (Diedrich
et al., 2018; Lee et al., 2019). The thermogenic capacity marker,
UCP1, functions to uncouple the oxidative phosphorylation
from ATP synthesis in the inner mitochondrial membrane and
dissipate energy in the form of heat. Beige adipocytes are also
described as UCP1+ cells with a dense mitochondrial network
and multilocular lipid droplets (Figure 1). In physiological
conditions, beige adipocytes act as white adipocytes, while
in response to environmental factors such as cold exposure,
exercise, cancer cachexia (CC), and tissue injury, their BAT-like
function is induced independently of UCP1 (Diedrich et al.,
2018; Ikeda et al., 2018). In contrast, the whitening of mouse
BAT adipocytes upon temperature change, leptin receptor
deficiency, β-adrenergic signaling inhibition, or lipase deficiency
leads to decreased mitochondrial content and increased
mitophagy (the autophagic degradation of mitochondria)
promoting WAT-like tissue formation (Altshuler-Keylin et al.,
2016; Ikeda et al., 2018; Kotzbeck et al., 2018). However, a
recent study suggests that warm-induced beige adipocyte
whitening is mostly based on morphological changes, while
beige adipocytes retain epigenetic memory (Roh et al., 2018).
Results obtained by scRNA-sequencing elucidated the activation
of CD44 and PDGFRα-expressing WAT progenitors, involved in
AT browning, through their proliferation and interaction with
macrophages (Burl et al., 2018). These findings provide important
insights into the capacity of AT to adopt environmental stimuli
and adjust to the physiological context by changing the
biochemical properties of mature adipocytes and APs.
ADIPOSITY PARAMETERS IN TUMOR
PATIENTS
The prognostic significance of adiposity at the point of cancer
diagnosis and prognosis is not completely clear. While some
studies showed an association between obesity and a poor
survival rate (Meyerhardt et al., 2003; Kasenda et al., 2014),
others have reported obesity to be associated with lower mortality
rates (Martin et al., 2013; Schlesinger et al., 2014; Ebadi et al.,
2017). Estimating the VAT index (VATI) and the SAT index
(SATI) as adiposity markers, SAT appears to correlate with
a reduction in mortality risk for gastrointestinal, respiratory
cancer, and renal carcinoma patients (Ebadi et al., 2017) and
an increased survival rate among patients with bone metastases,
thus demonstrating the prognostic value of AT distribution
(Chuang et al., 2020). In colorectal tumor patients, low SATI
and VATI are associated with an increased risk of dying, as did
high SAT and VAT density, where high VAT density was the
main predictor of a poor survival rate in metastatic colorectal
tumor patients (Charette et al., 2019). Breast tumor patients
with axillary lymph node metastasis had a significantly higher
VAT/SAT ratio than the patients without metastasis, suggesting
that the VAT/SAT ratio might be a useful biomarker of breast
tumor aggressiveness (Pahk et al., 2020). Moreover, breast tumor
patients exerted a high prevalence of BAT activity than did
patients suffering from other solid neoplasms (Singh et al.,
2016). Although marrow adiposity is an important contributor
to tumor progression in bones, distinguishing physiologic red
marrow re-conversion from marrow disease is still a challenge
for imaging-based diagnostics (Navarro et al., 2017). The marrow
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FIGURE 1 | The diversity of adipogenesis in a tumor milieu. The activation of different adipogenic programs in adipose tissue (AT) and tumors reveals the capacity of
adipogenic populations and neoplastic cells for phenotype conversion. In a tumor microenvironment, associated with low-grade inflammation, mature adipocytes
and resident APs adjust their biochemical profile (white to brown and brown to white) and commitment, respectively. The dashed arrow indicates the development of
tumor-supportive AT cells in response to tumor-derived factors. On the other hand, tumor cells can acquire adipogenic features, providing itself nutrition, survival,
and further development through mainly unknown intermediate phenotype states. Adipokines (leptin, resistin, PAI-1, lipocalin-2, and adiponectin), cytokines (IL-6,
TNF-α, and SCF), and chemokines (CXCL12) secreted by AT cells are indicated in the gray box, while tumor-derived factors are written in the blue box (Lengyel
et al., 2018). Abbreviations: IL, interleukin; CXCL, C-X-C motif chemokine ligand; TNF-α, tumor necrosis factor alpha; PAI-1, plasminogen activator inhibitor-1; SCF,
stem cell factor; PGE2, prostaglandin E2; UCP1, uncoupling protein 1; Myf5, myogenic factor 5; α-SMA, alpha-smooth muscle actin; Lin, lineage; PDGFR,
platelet-derived growth factor receptor; Pax7, paired box protein 7; AT, adipose tissue; AP, AT progenitor.
adipocyte area and diameter in acute myeloid leukemia (AML)
patients were shown to be smaller than those in healthy subjects,
thus indicating a prognostic value of these parameters (Lu
et al., 2018). Collectively, these data indicate that the AT profile
at different localizations could be clinically significant in the




Through metabolic reprogramming, the production of lipids,
and the secretion of hormones and adipokines, AT can
affect tumorigenesis, tumor growth, survival (Diedrich et al.,
2015), and even chemoresistance (Sheng et al., 2017). The
mechanisms underlying the effects of AT on tumor cells are
nicely summarized in a number of review articles (Diedrich
et al., 2015; Corrêa et al., 2019; Quail and Dannenberg, 2019).
However, AT–tumor interactions are reciprocal, as tumors affect
surrounding AT cells (mature adipocytes, preadipocytes, or APs),
by imposing their needs for the purpose of their own evolution.
Adipocytes located in close proximity to the invasive tumor
cells [often termed as tumor-associated adipocytes (TAAs)]
display a modified phenotype, metabolism, and secretome
(Figure 1). In addition to a fibroblast-like phenotype implying
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their dedifferentiation, TAAs are characterized by increased
production of inflammatory cytokines, chemokines, adipokines,
and high-energy metabolites (Dirat et al., 2011; Ribeiro et al.,
2012; Wu et al., 2019).
Moreover, as in the case of CC, systemic alterations
caused by the tumor may affect AT remodeling. CC is a
multifactorial syndrome that includes the progressive reduction
of body weight, associated with the reduction of adipose
(mostly WAT) and skeletal muscle tissues, which is often
considered a negative prognostic factor in cancer patients. The
tumor-provoked hypermetabolism in CC leads to a state of
energy imbalance that cannot be recovered through nutritional
supplementation (Kir and Spiegelman, 2016; Vaitkus and Celi,
2017). According to morphologic modifications, decreased lipid
content and a proinflammatory phenotype, cachectic adipocytes
are similar to TAAs (Rybinska et al., 2020). As recently
demonstrated, the downregulation of adipogenic and lipogenic
genes is affected early in AT, resulting in lipolysis and AT
remodeling during CC (Batista et al., 2013; Sun et al., 2020).
Also, CC is associated with fibrosis and inflammatory cell
infiltration in SAT (Batista et al., 2016), while VAT shows a
low lipolysis rate in the early stage of CC and a low de novo
lipogenesis rate in later stages. In addition, VAT adipocytes
as well as SVF isolated from rats were shown to produce
increased levels of IL-1β activating inflammasome pathway,
suggesting a proinflammatory phenotype of AT cells in CC
(Neves et al., 2016).
Another aspect of tumor-affected adipogenesis is related to
the stimulation of the browning process in AT. The increased
thermogenic activity of AT contributes to the accelerated energy
expenditure and weight loss in mouse models of CC whereby
IL-6 and parathyroid hormone-related protein, a tumor-derived
small polypeptide that modulates calcium homeostasis, were
identified as drivers of AT browning (Kir et al., 2014; Kir
and Spiegelman, 2016). Yet evidences on adipocyte browning
in CC in humans are still missing. Moreover, the white-to-
brown trans-differentiation of omental adipocytes was found in
patients affected by pheochromocytoma (Frontini et al., 2013)
and breast cancer where mammary tumor stem cells expressed
PRDM16, a master regulator of brown adipocyte differentiation
(Singh et al., 2016). The promoted beige/brown program also
correlates with stimulated adipocyte catabolism characterized
by the release of fatty acids, pyruvate, lactate, and ketone
bodies supplying tumor cells. Accordingly, hypermetabolic breast
tumor cells feature increased glucose uptake and triglyceride
accumulation (Kir and Spiegelman, 2016; Wu et al., 2019;
Figure 1).
Interestingly, tumor-provoked physical stresses can induce
adipocyte dedifferentiation into a state similar to MSCs, termed
as the compression-induced dedifferentiation of adipocytes,
characterized by a clonogenic and multilineage differentiation
capacity in vitro (Li et al., 2020). However, this observation
needs to be validated in human cancer in vivo, considering
that ASCs obtained from breast tumor patients display an
impaired adipogenic capability (Rey et al., 2019). Besides,
human ASCs from the intra-abdominal VAT of prostate cancer
patients primed with tumor-derived exosomes can undergo
neoplastic transformation exerting cytogenetic aberrations,
and a mesenchymal-to-epithelial transition, along with the
capacity to form tumors in vivo (Abd Elmageed et al.,
2014). Importantly, ASCs from periprostatic WAT of prostate
cancer patients promote tumor cell epithelial-to-mesenchymal
transition and cancer aggressiveness, while their depletion
might help chemotherapy efficiency in mice (Su et al., 2019).
Moreover, near the tumor cells of breast cancer patients, ASCs
(Jotzu et al., 2010) and stromal adipocytes (Bochet et al.,
2013) can form tumor-associated fibroblast-like cells. Also,
ASCs can be incorporated into blood vessels as pericytes
contributing to tumor progression and AT remodeling through
the pericyte–fibroblast transition (Zhang et al., 2012; Di Carlo
and Peduto, 2018) or adipogenesis (Hosaka et al., 2016). AT-
derived pericytes support tumor progression, since an acquired
pericytic phenotype was observed in liposarcoma (Shen et al.,
2016), and mammary carcinoma cells (Shenoy et al., 2016).
The trans-differentiation of mesenchymal breast tumor cells
into post-mitotic and functional adipocytes has recently been
demonstrated in murine and human breast cancer model
in vivo, along with its contribution to the inhibition of tumor
invasion and metastasis (Ishay-Ronen et al., 2019). These findings
demonstrate the importance of the behavior of the healthy and
neoplastic cells in AT remodeling, while also suggesting that the
pro-adipogenic program activation might be a useful approach in
anticancer drug conceptualization.
Bone Marrow Adipose Tissue and
Neoplasms
Bone marrow adipose tissue represents a distinct, heterogenous
fat depot with an important role in hematopoiesis, skeletal
biology, and tumors, known to provide a supportive
microenvironment for hematological malignancies, such as
multiple myeloma and leukemias, and a number of solid tumor
metastases including melanoma (Chen et al., 2016) and breast
and prostate tumors (Zhang et al., 2019). As BMAT expansion
during aging interferes with hematopoietic stem/progenitor cell
(HSPC) maintenance, BMAT appears as a negative regulator
of hematopoiesis (Naveiras et al., 2009; Ambrosi et al., 2017).
Nevertheless, a recent study suggested that stem cell growth
factor 1, produced by BMAT, supports primitive HSPC survival
in mice (Zhou et al., 2017), indicating the complex effects of
BMAT on neoplastic hematopoietic cells dependent on the
differentiation and disease stage.
Studies using mouse in vivo and human in vitro models
showed that BM adipocytes support the survival, proliferation,
and even chemoresistance of malignant cells. Adipokines
and free fatty acids released by BM adipocytes directly
or indirectly interfere with cells of bone remodeling or
hematopoiesis (Hardouin et al., 2016). Tumor cells can induce
the phosphorylation of hormone-sensitive lipase and activate
lipolysis in BMAT, allowing the transfer of fatty acids from
adipocytes to tumor cells in AML (Shafat et al., 2017; Tabe et al.,
2020), multiple myeloma (Morris et al., 2020), and prostate tumor
(Herroon et al., 2019). Importantly, after chemotherapy, marrow
necrosis and the loss of myeloid tissue may result in a BMAT
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 September 2020 | Volume 8 | Article 571648
fcell-08-571648 September 17, 2020 Time: 19:14 # 6
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expansion (Hwang and Panicek, 2007; Costa and Reagan, 2019),
which might create a favorable niche for tumor cells.
Moreover, metastatic tumor cells interact with medullar
adipocytes forming a specific metastatic niche in BM
(Morris and Edwards, 2016; Diedrich et al., 2018). BMAT
increases during an early stage of murine myeloma, where
marrow adipocytes localize along the tumor–bone interface
at later stages of the disease. In addition, myeloma cells
downregulate BMAT-derived adiponectin, adjusting the marrow
microenvironment to support cancer progression (Morris et al.,
2020). Myeloma cells also reprogram adipocytes via the increased
methylation of PPARγ and altered adipokine production, which
activates osteoclastogenesis and osteolytic lesion formation
(Liu et al., 2019).
Besides, tumor cells’ survival mechanisms can be activated
through the interplay of inflammatory and metabolic pathways
in BMAT. As such, metastatic prostate tumor cell-derived
IL-1β induced prostaglandin E2 expression and lipolysis in
BM adipocytes, coinciding with the pro-survival pathway
activation in tumor cells (Herroon et al., 2019). Also, BMAT-
induced reactive oxygen species (ROS) production and the
heme oxygenase-1 overexpression resulted in the activation of
survival molecules survivin (BIRC5) and Bcl-xl in metastatic
prostate and breast tumor cells (Diedrich et al., 2018; Herroon
et al., 2018). A recent study interestingly suggests that marrow
malignancy might affect the adipogenic commitment of resident
mesenchymal progenitors, since AML-derived MSCs showed
increased adipogenesis, supporting the survival of leukemia
progenitor cells (Azadniv et al., 2020).
CONCLUSION
Tumor-induced adaptations bring additional complexity to the
AT regulation of the healthy and abnormal cell phenotype.
Within the spectrum ranging from white to brown adipocytes,
the appearance of alternative adipogenic programs in mature
adipocytes and their precursors contributes to AT niche
remodeling, which occurs in parallel in tumor cells, suggesting
the indissolubility of the adipogenic differentiation and tumor
progression at the molecular level. The feasibility of cell “trans-
differentiation” with the adaptation of tumor cells into adipocyte-
like cells, and likely, the reversible conversion of the adipocyte
phenotype from the white to beige/brown adipocyte phenotype,
point to the possibility for new targets in drug development for
oncology patients (Lengyel et al., 2018). Nevertheless, the AT–
tumor microenvironment requires accurate comprehension of
the time course and stability of various differentiating adipogenic
lineages and tumor cell phenotype outcomes.
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